Comparing Lombard Medical (EVAR) and Its Peers
Lombard Medical (NASDAQ: EVAR) is one of 84 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it compare to its competitors? We will compare Lombard Medical to similar companies based on the strength of its analyst recommendations, institutional ownership, valuation, earnings, risk, profitability and dividends.
Insider & Institutional Ownership
40.2% of Lombard Medical shares are owned by institutional investors. Comparatively, 63.4% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 13.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
This is a breakdown of recent ratings and recommmendations for Lombard Medical and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Lombard Medical Competitors||322||1475||2583||105||2.55|
As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 5.06%. Given Lombard Medical’s competitors higher probable upside, analysts clearly believe Lombard Medical has less favorable growth aspects than its competitors.
Valuation & Earnings
This table compares Lombard Medical and its competitors gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Lombard Medical||$12.17 million||-$24.22 million||-0.30|
|Lombard Medical Competitors||$827.05 million||$159.46 million||33.06|
Lombard Medical’s competitors have higher revenue and earnings than Lombard Medical. Lombard Medical is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
This table compares Lombard Medical and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Lombard Medical Competitors||-128.72%||-37.35%||-10.53%|
Volatility and Risk
Lombard Medical has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, Lombard Medical’s competitors have a beta of 1.08, indicating that their average stock price is 8% more volatile than the S&P 500.
Lombard Medical competitors beat Lombard Medical on 8 of the 9 factors compared.
About Lombard Medical
Lombard Medical, Inc. is a medical technology company. The Company specializes in developing, manufacturing, and marketing endovascular stent-grafts that address medical needs in the repair of aortic aneurysms. The Company’s Aorfix is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of over 90 degrees. The Company supplies Aorfix pre-loaded into a delivery system, Aorflex, which is designed for accurate placement of Aorfix in the abdominal aorta. Once Aorfix is properly placed within the abdominal aorta, it provides a conduit for blood flow, thereby relieving pressure within the weakened or aneurysmal section of the vessel wall, which reduces the potential for the AAA to rupture. It also offers IntelliFlex, which is a delivery system technology created for Aorfix AAA stent graft, and Altura Endovascular Stent Graft System that offers a simple and predictable solution to the treatment of standard AAA anatomies.
Receive News & Ratings for Lombard Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lombard Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.